Organization & Developments: Translate Bio

Parents

*Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction.
2018: Translate Bio Could Be The Next Big Thing In Cystic Fibrosis seekingalpha.com
2019: Biotech Analysis Central Preview Series: Translate Bio_seekingalpha.com
2019: Translate Bio Should Be On Your Radar With Upcoming Presentation And CF Data In 2020 _ seekingalpha.com
2019: Translate Bio Suffers Clinical Hold But It Had Gone Through This Issue Before_seekingalpha.com
2020: Covid Report: Moderna And Other Vaccine Makers Catapult On Key Test
2020: Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies
2020: Sanofi Goes Big on $2 Billion-Plus Vaccine Partnership with Translate Bio
2020: Translate Bio Is Much More Than Just A Covid-19 Vaccine Biotech
2020: Translate Bio: Translating mRNA To Protein Expression Into Therapies
2021: Translate Bio's mRNA fails to improve lung function in cystic fibrosis patients